Cerno Bioscience has developed unique technologies that can expand, enhance, and greatly extend the utility of mass spectrometry in a number of established and evolving application areas, ranging from environmental applications, forensics, homeland security, drug and material impurities and degradents, metabonomics, proteomics, biomarker discovery, quantitative and qualitative analysis for drug discovery and development, and clinical diagnostics. Covered by over a dozen granted and pending world-wide patents these novel calibration and analysis techniques are derived from sound mathematical principles. Cerno methodologies can provide significant improvements to all types of MS data (Single Quad, Triple Quad, Ion Trap, TOF, qTOF, FTMS, Seldi-TOF, etc.). These technologies can show substantial benefits to MS analysis in the following areas: 

• Improved Mass Accuracy for low resolution quadrupole instruments (up to 5ppm)
• Improved Spectral Accuracy for all MS instruments (up to 99.9%)
• Effective noise filtering (Detection limit improvement 3x or more)